Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina Vitale

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Pharmacology|June 26, 2020
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled StudyValentina Giudice, Pasquale Pagliano, Alessandro Vatrella, et al.
Journal of Clinical Medicine|February 15, 2022
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous SystemsValeria Visco, Carolina Vitale, Antonella Rispoli, et al.
Allergy|June 27, 2020
The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergensGennaro D'Amato, Herberto Jose Chong-Neto, Olga Patricia Monge Ortega, et al.
British Journal of Pharmacology|November 21, 2024
Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patientsPaola Di Pietro, Angela Carmelita Abate, Carmine Izzo, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 15, 2022
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 28, 2024
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M StudyClaudia Crimi, Santi Nolasco, Alberto Noto, et al.
The World Allergy Organization Journal|July 25, 2015
Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy OrganizationGennaro D'Amato, Stephen T Holgate, Ruby Pawankar, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Pharmacology|June 26, 2020
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled StudyValentina Giudice, Pasquale Pagliano, Alessandro Vatrella, et al.
Journal of Clinical Medicine|February 15, 2022
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous SystemsValeria Visco, Carolina Vitale, Antonella Rispoli, et al.
Allergy|June 27, 2020
The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergensGennaro D'Amato, Herberto Jose Chong-Neto, Olga Patricia Monge Ortega, et al.
British Journal of Pharmacology|November 21, 2024
Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patientsPaola Di Pietro, Angela Carmelita Abate, Carmine Izzo, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 15, 2022
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 28, 2024
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M StudyClaudia Crimi, Santi Nolasco, Alberto Noto, et al.
The World Allergy Organization Journal|July 25, 2015
Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy OrganizationGennaro D'Amato, Stephen T Holgate, Ruby Pawankar, et al.
Pageof 4